ReviewInternational journal of molecular sciences2024

Advances in Anti-Cancer Drug Development: Metformin as Anti-Angiogenic Supplemental Treatment for Glioblastoma.

Siddharth Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.